Clinical Study Backs Claims Made by Skincare Brand SkinAx²

636087525874528747femme_dans_bulle.jpg

06 Sep 2016 --- SkinAx², a new anti-aging formula from the French Group Activ’Inside, has been backed by a published clinical study on its capacity to improve skin radiance by oral route.

The oral supplement provides both primary and secondary antioxidants for an optimal and synergistic protection against skin oxidation, combining french grape and melon extracts rich in polyphenols, as well as superOxide Dismutase (SOD), zinc and vitamin C.

The makers claim the antioxidant capacity of SkinAx² protects skin fibers from degradation, improves skin microcirculation and allows regulating melanin synthesis. This multifactorial way of action contributes to the complete effect of SkinAx² on the three main components of skin radiance: color, contract and imperfection.

It's these claims have now been backed by a clinical study conducted under dermatological control on 35 women. Using both subjective and objective methods, SkinAx² was found to improve skin radiance, including color, contrast and imperfection after 2 months of oral supplementation. 82 per cent of women enrolled on the study reported an even complexion and brighter skin.

Marion Dumoulin, co-author of the clinical study explained, “Contrary to most of skin anti-aging solutions, SkinAx² not only acts on a single parameter but has a full and complementary action on all factors involved in skin radiance."

Dumoulin added, “Consumer’s skin is more luminous, smoother and firmer, with less imperfections. Overall, more than 20 clinical results detailing the SkinAx² efficacy have been obtained, each representing one validated differentiating message for the final consumers.”

The innovation provided by SkinAx² on the nutricosmetic market has already been rewarded twice and has been selected as a finalist of CPG Editor’s Choice Award, whose winner will be selected at the upcoming Supply Side West event. This recognition of the product highlights the innovation conveyed by SkinAx² on the growing nutricosmetic market.

When asked how he thinks the nutricosmetic sector will move forward, Benoit Lemaire, Business & Marketing Director of Activ’Inside, told NutritionInsight: "In our opinion, the nutricosmetic industry will move to the development of ready to use formulations based on the combination of synergistic ingredients. Customers have growing interest in having a full formula backed by clinical studies and claims in order to accelerate their market access and to boost their communication"

Available both as an ingredient or a ready-to-use formulation for private labeling, Lemaire added that SkinAx² can be used adapted to the customer needs, explaining, "We propose turnkey concepts formulated with SkinAx² allowing our customers to access to the market with an innovative product backed by one clinical study, a patented formula, and proprietary claims.”

by Hannah Gardiner

Related Articles

Business News

Enzymotec and Frutarom merger gets shareholder green light

12 Dec 2017 --- The shareholders of Israeli specialty chemicals company Enzymotec Ltd. have approved by large majority the merger transaction between Frutarom and Enzymotec. The transaction was approved at Enzymotec’s General Meeting by 99.9 percent majority of shareholders present at the meeting and entitled to vote, Frutarom Industries Ltd. reports.

Nutrition & Health News

Relief from food allergies may come from antibody drug and food desensitization

12 Dec 2017 --- A clinical trial of 48 children with multiple food allergies which tested antibody drug omalizumab alongside food desensitization treatment resulted in more effective allergy relief compared to placebo, according to a study published in The Lancet Gastroenterology & Hepatology journal.

Nutrition & Health News

EVNol Tocotrienol may beat omeprazole in controlling gastric issues

12 Dec 2017 --- ExcelVite’s EVNol tocotrienol was found to be more effective in treating gastric growth factors in stress-exposed rats than omeprazole, a common medication used in the treatment of gastroesophageal reflux disease and peptic ulcer disease. This is according to a recently published study in the World Journal of Gastroenterology that suggests more investigation is warranted.
 

Business News

Nutrition 21 launches US media campaign to support Velositol ingredient

11 Dec 2017 --- Nutrition 21, LLC has partnered with NYC-based media relations firm Pitch Publicity and clinical pharmacist James B. LaValle in a national media tour dedicated to educating consumers about the benefits of its proprietary ingredient, Velositol.

Food Ingredients News

Pea stars for Roquette amid alternative protein boom

11 Dec 2017 --- Roquette’s range of pea proteins took a starring role at FiE 2017, and would seem to have a bright future in products promoted by the company. According to the company’s representatives, a key highlight of the company’s newest range of products is around plant-based proteins – many of which are based on pea proteins.

More Articles
URL : http://www.nutritioninsight.com:80/news/clinical-study-backs-claims-made-by-skincare-brand-skinax.html